Back to Paradigm Biocapital Advisors LP
Paradigm Biocapital Advisors LP
Q2 2026 13F filing
Updated 27 days ago28 disclosed positions worth $5.3B
Portfolio value
$5.3B
Total holdings
28
New positions
0
Closed positions
0
Increased
0
Decreased
0
Turnover
—
Filed
2026-08-14
Full holdings
Every line item disclosed in Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | R RVMDW REVOLUTION MEDICINES INC | $1.2B | 6.36M | 22.31% | — |
| 2 | ? N/A NUVALENT INC | $731.7M | 5.92M | 13.70% | — |
| 3 | E EWTX EDGEWISE THERAPEUTICS INC | $415.1M | 10.22M | 7.77% | — |
| 4 | G GNMSF GENMAB A/S | $360.8M | 13.13M | 6.76% | — |
| 5 | S SYRE SPYRE THERAPEUTICS INC | $341M | 3.84M | 6.38% | — |
| 6 | A APGE APOGEE THERAPEUTICS INC | $209.2M | 1.58M | 3.92% | — |
| 7 | O ORKA ORUKA THERAPEUTICS INC | $204.1M | 2.14M | 3.82% | — |
| 8 | T TNGX TANGO THERAPEUTICS INC | $198.7M | 6.36M | 3.72% | — |
| 9 | B BLTE BELITE BIO INC | $189.8M | 1.23M | 3.55% | — |
| 10 | E EQR ERASCA INC | $175M | 9.55M | 3.28% | — |
| 11 | T TARS TARSUS PHARMACEUTICALS INC | $174.7M | 2.78M | 3.27% | — |
| 12 | A ALNY ALNYLAM PHARMACEUTICALS INC | $144.5M | 480.0K | 2.71% | — |
| 13 | I INSM INSMED INC | $141.4M | 1.33M | 2.65% | — |
| 14 | M MBX MBX BIOSCIENCES INC | $138.4M | 2.51M | 2.59% | — |
| 15 | P PCVX VAXCYTE INC | $123.7M | 2.13M | 2.32% | — |
| 16 | V VRDN VIRIDIAN THERAPEUTICS INC | $123.5M | 6.72M | 2.31% | — |
| 17 | O OLMA OLEMA PHARMACEUTICALS INC | $108.5M | 8.67M | 2.03% | — |
| 18 | J JBIO JADE BIOSCIENCES INC | $63.5M | 2.86M | 1.19% | — |
| 19 | T TYRA TYRA BIOSCIENCES INC | $58.4M | 1.83M | 1.09% | — |
| 20 | A ASH ASSEMBLY BIOSCIENCES INC | $42.7M | 1.55M | 0.80% | — |
| 21 | ? N/A EYEPOINT INC | $41.3M | 2.89M | 0.77% | — |
| 22 | A ACHV ACHIEVE LIFE SCIENCE INC | $32.3M | 4.95M | 0.61% | — |
| 23 | V VOR VOR BIOPHARMA INC | $32.2M | 1.75M | 0.60% | — |
| 24 | M MPLT MAPLIGHT THERAPEUTICS INC | $24.6M | 685.9K | 0.46% | — |
| 25 | ? N/A KARDIGAN INC | $21.5M | 900.0K | 0.40% | — |
| 26 | ? N/A LEXEO THERAPEUTICS INC | $19.4M | 4.18M | 0.36% | — |
| 27 | E EIX EDITAS MEDICINE INC | $18.1M | 5.59M | 0.34% | — |
| 28 | I IVEVF INVENTIVA SA | $15.1M | 4.00M | 0.28% | — |